A recent phase 2 clinical trial has shown that radiotherapy directed at metastases (stereotactic radiotherapy) resulted in promising survival rates and low side effects for patients with metastatic clear cell kidney cancer who had up to five metastases (oligometastatic disease) without the need for anti-cancer medication.

Read more on our website here:

Every year, the NHS finds out what cancer patients think about cancer services. To do this, they send out a survey to cancer patients and their families. This report looks at the main things people said about the cancer care they got in 2024.

See the highlights of the report on our website here:

We are thinking of Donna Pallot and @Michelle Ashley they are doing a skydive today to raise funds for us. Thank you so much you are so brave!

Today would have been their sisters Sarah’s 46th birthday and to honour her memory Michelle and Donna are doing the skydive.

They are raising funds for us to ensure that others who are battling kidney cancer receive the support and care they need and to raise awareness of kidney cancer.

If you would like to read more about Sarah pleaser follow the link below:
https://actionkidneycancer.org/.../a-skydive-in-memory.../

#kidney cancer #bypatientsforpatients #StrongerTogether

Great news - Hundreds of people in Wakefield and across the region will benefit from life-saving abdomen scans following new funding from Yorkshire Cancer Research.

Read more on our website here:

In an interesting European study of second-line treatments for metastatic kidney cancer that does not respond to first-line treatment, or becomes resistant to first-line treatment (refractory kidney cancer), cabozantinib was the most commonly used treatment and results in good outcomes for patients.

Read more on our website here: